-
Out-of-Pocket Expenditures of Families Affected by Epidermolysis Bullosa in Europe
Sep 9, 2025, 16:22 PM -
How the EU JCA Could Interface With Regional Pricing Alliances (BeNeLuxA, Nordic Forum, Valletta Group) and EU-Level Procurement Under the Critical Medicines Act
Sep 9, 2025, 16:22 PM -
Human Metapneumovirus (hMPV): Systematic Literature Review of Economic and Humanistic Disease Burden in Adults
Sep 9, 2025, 16:22 PM -
Surviving but Not Earning? Long-term Income Trajectories in Working-Age mIDH Glioma Patients: Stratification by Radiotherapy/Chemotherapy Exposure
Sep 9, 2025, 16:22 PM -
Can Generative Artificial Intelligence (GenAI) Be Leveraged to Automate Scoping Searches of Systematic Literature Reviews (SLRs)?
Sep 9, 2025, 16:22 PM -
Review of Surrogate Endpoints’ Acceptance Trends in German HTA and Implications for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Assessing the Environmental Value of Semaglutide: Reduction in GHG Emissions Resulting From the Treatment of Obese Individuals With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
A Model-Based Estimation of Productivity-Adjusted Life Years Due to Depression in Germany
Sep 9, 2025, 16:22 PM -
Investigating the Importance of EQ-5D Domains and Two Bolt-on Items: How Do the Preferences of People With Acute Leukemia Differ From the General Population?
Sep 9, 2025, 16:22 PM -
An Interactive R-Shiny Application for Budget Impact Modeling of Cell and Gene Therapies With Multiple Innovative Payment Scenarios
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review of the Mitigation Strategies to Overcome the Risk for Confounding of Overall Survival in Trials With Crossover/Treatment Switching Evaluated in Health Technology Assessments of Treatments for Select Tumors in Oncology
Sep 9, 2025, 16:22 PM -
Access to Decide on a Generalization: Results From the EVA-Corse Experiment: Efficiency and Clinical Non-Inferiority of a Hybrid Cardiac Rehabilitation Model in Corsica
Sep 9, 2025, 16:22 PM -
Characteristics Associated With Having an Activity of Daily Living Limitation (ADLL) or Instrumental Activity of Daily Living Limitation (IADLL) Among US Adults With Asthma
Sep 9, 2025, 16:22 PM -
Impact of Different Thresholds of Increasing or Decreasing Body Mass Index on Noncommunicable Diseases Through a Discrete Event Simulation Model
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of TEVAR With Active Control in Patients With TAA and TBAD: A Japanese Public Healthcare Payer Perspective
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Standard-Dose vs. High-Dose Influenza Vaccination in Adults Aged ≥65 Years in Italy
Sep 9, 2025, 16:22 PM -
Review of Rare Disease Policy Developments in Europe and Türkiye 2020-2025 in the Context of Innovative Orphan Drugs
Sep 9, 2025, 16:22 PM -
Real-World Insights From the LOGEX IMID Observatory: A Multicountry, Multiyear Analysis of Treatment Pathways and Healthcare Resource Utilization in Immune-Mediated Inflammatory Diseases
Sep 9, 2025, 16:22 PM -
The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece
Sep 9, 2025, 16:22 PM -
Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants
Sep 9, 2025, 16:22 PM
